Target intelligence / Profile preview

DTNA antisense RNA 1 (DTNA-AS1)

Target: DTNA-AS1
Molecular classification: non-coding RNA, natural antisense transcript

Overview

There is no evidence in the provided or recent literature that a molecule or gene named "DTNA antisense RNA 1" or "DTNA-AS1" exists as a recognized, characterized gene, non-coding RNA, or therapeutic target. "Antisense RNA 1" is a common naming pattern for natural antisense transcripts (NATs), but no such transcript has been linked to the DTNA (dystrobrevin alpha) gene in curated biomedical databases or the scientific literature. The absence suggests the target name may be misspelled, not established, or not biologically recognized at this time.

Other names: DTNA-AS1Antisense RNA 1

Beyond the preview

Go deeper on DTNA antisense RNA 1 (DTNA-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DTNA antisense RNA 1 (DTNA-AS1).

Explore the full profile